1 / 6

Allergy Immunotherapy Market Size Analysis

Allergy Immunotherapy Market Size Analysis

Download Presentation

Allergy Immunotherapy Market Size Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Allergy Immunotherapy Market Research Report - Forecast to 2023 Global Industry Survey, Growth, Competitive Landscapeand Forecasts to 2023 CREATED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

  2. Allergy Immunotherapy Market Research Report - Forecast to 2023 Research Across Sectors to Give Impetus to Global Allergy Immunotherapy Market 2023 • The allergy immunotherapy market is predicted to touch USD 4, 324.7 million at a 10.85% CAGR between 2016-2023, reveals the latest Market Research Future (MRFR) report. Allergen immunotherapy or allergy shots, simply put, is a long-term treatment that helps in decreasing symptoms for many with stinging insect allergy, eye allergy, allergic asthma, and allergic rhinitis. Its effectiveness rests on the dosage of the allergen and the duration of the treatment program. This treatment is generally recommended for those suffering from severe allergy symptoms, not responding to usual medications. Allergy immunotherapy is also effective for those having side effects from medications, those for whom allergies have become life-threatening, and people finding their lives disrupted by allergies. Moreover, it also helps in reducing the severity of reactions resulting from insect stings.  • On the flip side, limited applications of allergy immunotherapy and restricted healthcare spending are factors that may deter the allergy immunotherapy market growth over the forecast period. Browse Report Details @ https://www.marketresearchfuture.com/reports/allergy-immunotherapy-market-1517 www.marketresearchfuture.com

  3. Allergy Immunotherapy Market Research Report - Forecast to 2023 Segmentation: • The Market Research Future report provides an all-inclusive segmental analysis of the allergy immunotherapy market on the basis of treatment and allergy type.   • Based on allergy type, the allergy immunotherapy market is segmented into peanut allergy, allergic rhinitis, allergic asthma, cat allergy, and other allergies. Of these, the allergic rhinitis segment will have the largest share in the market during the forecast period chiefly owing to its growing prevalence among children and adults alike. • Based on treatment, the allergy immunotherapy market is segmented into specific immunotherapy (SIT), subcutaneous immunotherapy (SCIT), and sublingual immunotherapy. The sublingual immunotherapy segment is again segmented into sublingual immunotherapy drops and sublingual immunotherapy tablets. Of these, the subcutaneous immunotherapy segment will dominate the market during the forecast period. Factors pushing the growth of this segment include its effectiveness in treating various types of allergies, such as asthma. Moreover, this is a treatment option that alters the immune system for preventing the development of other types of allergies.  Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1517 www.marketresearchfuture.com

  4. Allergy Immunotherapy Market Research Report - Forecast to 2023 Application & Major Players in this Research: Allergy Immunotherapy Market Prominent Players: Major players profiled in the allergy immunotherapy market report include HAL Allergy Group (Netherlands), Stallergenes Greer (UK), ALK Abello A/S (Denmark), DBV Technologies (France), Circassia (UK), Merck KGaA (Allergopharma) (Germany), and Allergy Therapeutics (UK), among others. October 2019: A graduate student from the department of immunology in the Max Rady College of Medicine has developed a new drug for combating allergic asthma. Get Discount @ https://www.marketresearchfuture.com/check-discount/1517 www.marketresearchfuture.com

  5. Allergy Immunotherapy Market Research Report - Forecast to 2023 About Us: Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. www.marketresearchfuture.com

  6. MARKET RESEARCH FUTURE THANK YOU salesteam@marketresearchfuture.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) www.marketresearchfuture.com

More Related